Sam-A Pharm. Statistics

Total Valuation

Sam-A Pharm. has a market cap or net worth of KRW 102.84 billion. The enterprise value is 40.72 billion.

Market Cap	102.84B
Enterprise Value	40.72B

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	6.10M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	68.45%
Owned by Institutions (%)	n/a
Float	1.93M

Valuation Ratios

The trailing PE ratio is 4.52.

PE Ratio	4.52
Forward PE	n/a
PS Ratio	1.01
PB Ratio	0.48
P/TBV Ratio	0.49
P/FCF Ratio	4.00
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.42, with an EV/FCF ratio of 1.58.

EV / Earnings	1.79
EV / Sales	0.40
EV / EBITDA	1.42
EV / EBIT	1.67
EV / FCF	1.58

Financial Position

The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.05.

Current Ratio	4.75
Quick Ratio	4.15
Debt / Equity	0.05
Debt / EBITDA	0.37
Debt / FCF	0.42
Interest Coverage	114.75

Financial Efficiency

Return on equity (ROE) is 11.11% and return on invested capital (ROIC) is 7.40%.

Return on Equity (ROE)	11.11%
Return on Assets (ROA)	6.79%
Return on Capital (ROIC)	7.40%
Revenue Per Employee	337.98M
Profits Per Employee	75.89M
Employee Count	300
Asset Turnover	0.44
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.46% in the last 52 weeks. The beta is 0.37, so Sam-A Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+7.46%
50-Day Moving Average	17,433.60
200-Day Moving Average	20,984.40
Relative Strength Index (RSI)	42.44
Average Volume (20 Days)	13,696

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sam-A Pharm. had revenue of KRW 101.39 billion and earned 22.77 billion in profits. Earnings per share was 3,730.82.

Revenue	101.39B
Gross Profit	64.81B
Operating Income	25.21B
Pretax Income	30.15B
Net Income	22.77B
EBITDA	29.47B
EBIT	25.21B
Earnings Per Share (EPS)	3,730.82

Full Income Statement

Balance Sheet

The company has 72.97 billion in cash and 10.85 billion in debt, giving a net cash position of 62.12 billion or 10,178.55 per share.

Cash & Cash Equivalents	72.97B
Total Debt	10.85B
Net Cash	62.12B
Net Cash Per Share	10,178.55
Equity (Book Value)	213.98B
Book Value Per Share	35,060.22
Working Capital	86.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.53 billion and capital expenditures -6.81 billion, giving a free cash flow of 25.72 billion.

Operating Cash Flow	32.53B
Capital Expenditures	-6.81B
Free Cash Flow	25.72B
FCF Per Share	4,213.72

Full Cash Flow Statement

Margins

Gross margin is 63.92%, with operating and profit margins of 24.87% and 22.46%.

Gross Margin	63.92%
Operating Margin	24.87%
Pretax Margin	29.74%
Profit Margin	22.46%
EBITDA Margin	29.07%
EBIT Margin	24.87%
FCF Margin	25.36%

Dividends & Yields

This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 4.40%.

Dividend Per Share	750.00
Dividend Yield	4.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	20.10%
Buyback Yield	0.03%
Shareholder Yield	4.44%
Earnings Yield	22.14%
FCF Yield	25.01%

Dividend Details

Stock Splits

The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.

Last Split Date	Dec 29, 2008
Split Type	Forward
Split Ratio	1.02005

Scores

Sam-A Pharm. has an Altman Z-Score of 4.55.

Altman Z-Score	4.55
Piotroski F-Score	n/a